Dougados, M., Kissel, K., Sheeran, T., Tak, P. P., Conaghan, P. G., Martín Mola, E., . . . Huizinga, T. W. J. (2013). Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY). Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU).
Chicago-Zitierstil (17. Ausg.)Dougados, Maxime, et al. Adding Tocilizumab or Switching to Tocilizumab Monotherapy in Methotrexate Inadequate Responders: 24-week Symptomatic and Structural Results of a 2-year Randomised Controlled Strategy Trial in Rheumatoid Arthritis (ACT-RAY). Erlangen: Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2013.
MLA-Zitierstil (9. Ausg.)Dougados, Maxime, et al. Adding Tocilizumab or Switching to Tocilizumab Monotherapy in Methotrexate Inadequate Responders: 24-week Symptomatic and Structural Results of a 2-year Randomised Controlled Strategy Trial in Rheumatoid Arthritis (ACT-RAY). Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2013.